Biomechanics

Catalyst OrthoScience Announces Amy Ables, Ph.D. as Chief Strategy Officer

Retrieved on: 
Monday, November 20, 2023

Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has appointed Amy Ables, Ph.D .

Key Points: 
  • Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has appointed Amy Ables, Ph.D .
  • as chief strategy officer of the organization, effective immediately.
  • View the full release here: https://www.businesswire.com/news/home/20231120034416/en/
    Catalyst OrthoScience Announces Amy Ables, Ph.D. as Chief Strategy Officer (Photo: Business Wire)
    “The board and I are excited to have an executive with Dr. Ables’ experience and leadership join our team at Catalyst OrthoScience,” said Catalyst CEO and President Carl O’Connell .
  • Prior to Cutera and through the peak of the COVID-19 pandemic, Ables was the chief learning officer at Vyaire Medical, a global organization focused on respiratory care.

2023 Corrective Exercise Specialist of the Year Award Recipient Named

Retrieved on: 
Wednesday, June 21, 2023

BELTON, Texas, June 21, 2023 /PRNewswire-PRWeb/ -- The BioMechanics Method, the highest-rated provider of corrective exercise education for fitness, exercise and health professionals, is pleased to name Ryan Vivar as the Corrective Exercise Specialist of the Year® for 2023. The Corrective Exercise Specialist of the Year award recognizes an individual who is certified in The BioMechanics Method, currently providing corrective exercise services to clients/patients, and has demonstrated exceptional application of their corrective exercise skills.

Key Points: 
  • BELTON, Texas, June 21, 2023 /PRNewswire-PRWeb/ -- The BioMechanics Method, the highest-rated provider of corrective exercise education for fitness, exercise and health professionals, is pleased to name Ryan Vivar as the Corrective Exercise Specialist of the Year® for 2023.
  • The Corrective Exercise Specialist of the Year award recognizes an individual who is certified in The BioMechanics Method , currently providing corrective exercise services to clients/patients, and has demonstrated exceptional application of their corrective exercise skills.
  • As the 2023 Corrective Exercise Specialist of the Year, Ryan will serve as a spokesperson on corrective exercise for The BioMechanics Method.
  • Finalists for the 2023 Corrective Exercise Specialist of the Year® award were Lynne Olsen, Yoga Medicine Therapeutic Specialist and owner of Rolling Brook Yoga in Catonsville, MD and Rhonda Collins, owner of Body Longevity in Brisbane, Australia.

Walden Biosciences Promotes Curt Dewan, CFA to Chief Financial Officer

Retrieved on: 
Wednesday, April 5, 2023

CAMBRIDGE, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today announced the promotion of Curt Dewan, CFA to Chief Financial Officer.

Key Points: 
  • CAMBRIDGE, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today announced the promotion of Curt Dewan, CFA to Chief Financial Officer.
  • Mr. Dewan will serve as the Company’s first Chief Financial Officer and will continue to report to Blaine McKee, Ph.D., Chief Executive Officer of Walden Biosciences.
  • Curt is a capable leader who has been an integral part of Walden’s early growth.
  • Prior to joining Walden, Curt served as a business development executive at Servier Pharmaceuticals and held numerous financial leadership roles of increasing responsibility at Shire (acquired by Takeda), reaching the level of Head of Financial Planning.

MEA Forensic Engineers & Scientists are Proud to Announce 3 New Owners

Retrieved on: 
Friday, September 23, 2022

"They are truly inspiring people, and I trust them to look after MEA Forensic."

Key Points: 
  • "They are truly inspiring people, and I trust them to look after MEA Forensic."
  • They are truly inspiring people, and I trust them to look after MEA Forensic.
  • MEA Forensic Engineers & Scientists is a multi-disciplinary forensic investigations firm.
  • Having worked on over 50,000 cases and published 250 scientific studies over the last 40 years, MEA Forensic sets the standard for high-quality forensic engineering and science.

Leading Brands Leverage Aetrex’s 3D Foot Scanning Technology to Enhance Fit and Performance

Retrieved on: 
Tuesday, August 16, 2022

Aetrex, Inc. (Aetrex) , the global market leader in foot scanning technology, orthotics and comfort & wellness footwear, today announced its Albert 2 Pro foot scanning technology is being used in performance labs of notable brand partners, including BOA Technology Inc. , makers of the BOA Fit System, to enhance the performance of their fit systems and footwear of global leading brand partners.

Key Points: 
  • Aetrex, Inc. (Aetrex) , the global market leader in foot scanning technology, orthotics and comfort & wellness footwear, today announced its Albert 2 Pro foot scanning technology is being used in performance labs of notable brand partners, including BOA Technology Inc. , makers of the BOA Fit System, to enhance the performance of their fit systems and footwear of global leading brand partners.
  • Thus, we ensure footwear from industry leading brand partners garner the maximum performance benefits of the BOA Fit System.
  • More recently, Burton is among many performance brand partners acquiring an Albert 2 Pro to help inform the best fit through scientific data.
  • Aetrex Worldwide, Inc. is widely recognized as the global leader in foot scanning technology, orthotics, and comfort and wellness footwear.

Extremity Medical Partners with Dr. Joel Vernois to Develop Novel Minimally Invasive Surgery Techniques for Foot and Ankle Surgery

Retrieved on: 
Friday, May 13, 2022

Extremity Medical, a global medical device company focused on the development of innovative implants and instruments for upper and lower extremities, today announced that Dr. Joel Vernois has partnered with Extremity Medical to develop novel minimally invasive surgery (MIS) techniques and specialized instrumentation for foot and ankle surgery.

Key Points: 
  • Extremity Medical, a global medical device company focused on the development of innovative implants and instruments for upper and lower extremities, today announced that Dr. Joel Vernois has partnered with Extremity Medical to develop novel minimally invasive surgery (MIS) techniques and specialized instrumentation for foot and ankle surgery.
  • Dr. Vernois will also help Extremity Medical develop medical educational courses that focus on these MIS techniques.
  • He is a specialist in foot and ankle surgery and one of the leading innovators in MIS techniques.
  • He is the Past President of the Minimally Invasive Foot & Ankle Society (MIFAS) and the Research group for Foot Mini-Invasive Surgery.

KYOCERA’s New “HAPTIVITY® i" Revolutionizes Human-Machine Interface (HMI)

Retrieved on: 
Monday, December 20, 2021

KYOCERA Corporation (President and CEO: Hideo Tanimoto) today unveiled its HAPTIVITY i human-machine interface (HMI) technology a hybrid innovation combining its patented HAPTIVITY touch technology with IMSETM, a patented 3D injection-molded structural electronics technology from TactoTek Oy (CEO: Jussi Harvela).

Key Points: 
  • KYOCERA Corporation (President and CEO: Hideo Tanimoto) today unveiled its HAPTIVITY i human-machine interface (HMI) technology a hybrid innovation combining its patented HAPTIVITY touch technology with IMSETM, a patented 3D injection-molded structural electronics technology from TactoTek Oy (CEO: Jussi Harvela).
  • Additionally, because they are fully integrated and seamless, HAPTIVITY i solutions offer an interface that is reliable, durable, protected from debris and moisture, and easy to clean.
  • Kyocera will continue to develop modules equipped with HAPTIVITY i, integrated with a wide range of other Kyocera products and technologies to advance cutting-edge HMI applications.
  • For more information on how HAPTIVITY i technology can support your HMI requirements, please contact Kyocera at [email protected] .

Nextiles Launches Software Development Kit, Enabling All Industries to Access Novel Data Capture and Machine Learning Insights

Retrieved on: 
Tuesday, July 20, 2021

Industries such as sleep, sports and performance, and fitness are now able to partner with Nextiles to capture human movement data seamlessly via Bluetooth, and create proprietary machine learning algorithms to augment their own existing platforms.

Key Points: 
  • Industries such as sleep, sports and performance, and fitness are now able to partner with Nextiles to capture human movement data seamlessly via Bluetooth, and create proprietary machine learning algorithms to augment their own existing platforms.
  • Nextiles has developed smart thread technology to capture biometric and biomechanical data through flexible material and helps its partners build custom backends, which produce novel insights from manufactured soft goods.
  • By capturing these novel datasets, partners of Nextiles are able to build proprietary algorithms for each use case and personalize insights through machine learning.
  • Founded in 2018, Nextiles is an innovative materials science and manufacturing company, developing personalized, fabric-based sensors to capture biometric and biomechanics data.

Integra LifeSciences Receives Innovative Technology Contract from Vizient for SurgiMend® Collagen Matrix for Soft Tissue Reconstruction

Retrieved on: 
Wednesday, July 14, 2021

PRINCETON, N.J., July 14, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, announced its SurgiMend Collagen Matrix for Soft Tissue Reconstruction has received an Innovative Technology contract from Vizient, Inc. the nations largest member-driven health care performance improvement company.

Key Points: 
  • PRINCETON, N.J., July 14, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, announced its SurgiMend Collagen Matrix for Soft Tissue Reconstruction has received an Innovative Technology contract from Vizient, Inc. the nations largest member-driven health care performance improvement company.
  • Innovative Technology contracts are recommended after review and interaction with products submitted through Vizients Innovative Technology Program.
  • We are pleased that Vizient has selected SurgiMend as an innovative technology, said Dean Sollami, vice president of sales at Integra.
  • Our member council determined that SurgiMend Collagen Matrix for Soft Tissue Reconstruction met this standard and recognizes its potential to improve quality outcomes.

TELA Bio to Participate in Upcoming Investor Conferences

Retrieved on: 
Friday, May 21, 2021

b'MALVERN, Pa., May 21, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the Company plans to participate in two upcoming investor conferences.\nTELA Bio\'s management will be participating in the UBS Global Healthcare Virtual Conference on Monday, May 24, 2021 at 8:00 AM EST.

Key Points: 
  • b'MALVERN, Pa., May 21, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the Company plans to participate in two upcoming investor conferences.\nTELA Bio\'s management will be participating in the UBS Global Healthcare Virtual Conference on Monday, May 24, 2021 at 8:00 AM EST.
  • Interested parties can access the live and archived webcast at ir.telabio.com .\nTELA Bio\'s management is also scheduled to present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 3:30 PM EST.
  • Interested parties can access the live and archived webcast at ir.telabio.com .\nTELA Bio Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
  • TELA Bio\'s OviTex\xc2\xae and OviTex PRS Reinforced Tissue Matrix products are purposefully designed to address the shortcomings of existing reinforcement materials in hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery.